iMPak Health announces NFC mobile health application

iMPak Health, LLC announced today the launch of their new product, RhythmTrak, a Near Field Communication (NFC) enabled cardiovascular mobile health and wellness application. RhythmTrak is being launched on the Android Platform for both smart phones and tablets and the company plans to have the application on the iOS platform by the end of the year.

RhythmTrak is a handheld, credit card sized ECG device that documents heart rates, heart rate variability, calculates R to R intervals, and single lead waveforms. Data collected on the device is transmitted wirelessly using a NFC reader or an NFC enabled smart phone or tablet. The user then can simply forward the information to their physician. RhythmTrak is not intended to be a diagnostic device, but to be used to track patient symptoms during the active management of atrial fibrillation.

According to the American Heart Association, about 2 million Americans suffer from atrial fibrillation and related cardiac illness, putting them at risk for heart attacks and strokes. “Linking personal monitoring technologies such as RhythmTrak to practical everyday clinical protocols will improve the ability of both the clinician and the patient to better manage chronic conditions” said Richard Scott, M.D., Senior Vice President, Clinical Effectiveness, Meridian Health.

“It can be incredibly empowering for a patient to have a tool that helps them work with their physician to determine if they may need a change in medication or therapy, especially when it comes to overall heart health,” added Sandra Elliott, director, Consumer Technology and Service Development, Meridian Health. “Even patients undergoing ablation, a surgical procedure sometimes used to treat atrial fibrillation may still have symptoms after their procedure. The key is to understand if patients show improvement over time.”

RhythmTrak is expected to cost $39.99 when it hits the market. iMPak Health has submitted RhythmTrak for FDA approval in the United States and CE approval in the European Market.

For more information about RhythmTrak please visit http://www.impakhealth.com/cardiovascular-health.